Showing results (151-160 of 169) with videos related to

Sort By:
Pageof 17
European Journal of Medicinal Chemistry|October 12, 2020
Design, synthesis and biological evaluation of second-generation benzoylpiperidine derivatives as reversible monoacylglycerol lipase (MAGL) inhibitorsCarlotta Granchi, Giulia Bononi, Rebecca Ferrisi, et al.
Journal of Medicinal Chemistry|January 9, 2018
Discovery of 1,5-Diphenylpyrazole-3-Carboxamide Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) InhibitorsMojgan Aghazadeh Tabrizi, Pier Giovanni Baraldi, Stefania Baraldi, et al.
Journal of Medicinal Chemistry|May 6, 2022
Reversible Monoacylglycerol Lipase Inhibitors: Discovery of a New Class of Benzylpiperidine DerivativesGiulia Bononi, Miriana Di Stefano, Giulio Poli, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 7, 2017
Chemical probes to potently and selectively inhibit endocannabinoid cellular reuptakeAndrea Chicca, Simon Nicolussi, Ruben Bartholomäus, et al.
Journal of Medicinal Chemistry|December 19, 2009
Structure-activity relationship and mechanism of action studies of manzamine analogues for the control of neuroinflammation and cerebral infectionsJiangnan Peng, Sucheta Kudrimoti, Sivaprakasam Prasanna, et al.
The Journal of Biological Chemistry|July 31, 2016
Cannabinoid Receptor 2 Modulates Susceptibility to Experimental Cerebral Malaria through a CCL17-dependent MechanismJudith Alferink, Sabine Specht, Hannah Arends, et al.
Cell Reports|March 31, 2026
Targeting PI3Kδ suppresses pancreatic cancer by dual disruption of fibrosis and immune evasionMaciej Garczyk, Gonçalo Outeiro-Pinho, Muthita Pitaktrairat, et al.
European Journal of Medicinal Chemistry|November 17, 2023
Design, synthesis, ADME and biological evaluation of benzylpiperidine and benzylpiperazine derivatives as novel reversible monoacylglycerol lipase (MAGL) inhibitorsMiriana Di Stefano, Samuele Masoni, Giulia Bononi, et al.
Molecular Psychiatry|August 22, 2018
Dysfunction of homeostatic control of dopamine by astrocytes in the developing prefrontal cortex leads to cognitive impairmentsFrancesco Petrelli, Glenn Dallérac, Luca Pucci, et al.
Pageof 17